Generic Name: Rybrevant ()
Rybrevant Reviews
For Non Small Cell Lung Cancer "I've had quite a good result so far with initial shrinking, then stabilizing, of the NSCLC. I've had one reduction in dose since starting 10 months ago. The side effects are at times difficult to cope with, including a severe infected facial rash, painful paronychia, and edema. The meds I have been given for these conditions have little effect, including many courses of antibiotics, steroid creams, etc. I think if the side effects were better controlled, it would be easier to deal with the illness itself."
For Non Small Cell Lung Cancer "I have had all of the side effects since starting Rybrevant on March 24. In fact, they tried Keytruda for my first course of treatment, and after 3 treatments, a CT scan was taken, and it was not working. Hence, the reason for starting Rybrevant. It'll kick your butt! Like I said, I've had all the side effects. The skin issues are the worst, and the edema of my right foot. BUT, after 2 treatments then a CT scan, my tumor in my lung has shrunk to less than half its size. So, I will continue the treatments and deal with the side effects for now. We'll see, after the next scan, if it's still working. Hang in there."
More about Rybrevant (amivantamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bispecific antibodies
- Breastfeeding
Patient resources
- Rybrevant drug information
Professional resources
- Rybrevant Injection prescribing information
- Amivantamab-vmjw (AHFS Monograph)
Related treatment guides
- Non Small Cell Lung Cancer
